id: Q9UG63
gene_symbol: ABCF2
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  ABCF2 encodes ATP-binding cassette sub-family F member 2, a soluble member of
  the ABCF family with two ABC nucleotide-binding domains and no transmembrane
  domains. It is best described as a cytosolic ABC-family ATPase rather than a
  membrane transporter. ABCF2 expression is regulated by NFE2L2/NRF2 through a
  promoter antioxidant-response element in ovarian cancer cells, where altered
  ABCF2 abundance affects cisplatin sensitivity, but the direct molecular
  mechanism linking ABCF2 to drug resistance remains unresolved. ABCF2 has also
  been reported as a putative anti-apoptotic host factor that is bound and
  destabilized by the enteropathogenic Escherichia coli type III effector EspF,
  with cytoplasmic and partial mitochondrial localization, consistent with a
  role in restraining the intrinsic (mitochondrial) apoptotic pathway.
alternative_products:
- name: '1'
  id: Q9UG63-1
- name: '2'
  id: Q9UG63-2
  sequence_note: VSP_054715
existing_annotations:
- term:
    id: GO:0005524
    label: ATP binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      ABCF2 has two ABC nucleotide-binding domains and conserved ATP-binding
      motifs. ATP binding is therefore well supported as a core molecular
      property of the protein.
    action: ACCEPT
    reason: >-
      The phylogenetic annotation is consistent with UniProt feature annotation
      of two ABC transporter domains and two ATP-binding sites. This does not
      imply that ABCF2 is a membrane transporter.
    supported_by:
    - reference_id: file:human/ABCF2/ABCF2-uniprot.txt
      supporting_text: >-
        DOMAIN          86..325
    - reference_id: file:human/ABCF2/ABCF2-uniprot.txt
      supporting_text: >-
        BINDING         118..125
- term:
    id: GO:0005524
    label: ATP binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      InterPro-based ATP-binding annotation is consistent with the two
      ABC-transporter-like nucleotide-binding domains in ABCF2.
    action: ACCEPT
    reason: >-
      The domain architecture supports ATP binding. The annotation is generic
      but appropriate for ABCF2's molecular-function model.
    supported_by:
    - reference_id: file:human/ABCF2/ABCF2-uniprot.txt
      supporting_text: >-
        DOMAIN          396..613
    - reference_id: file:human/ABCF2/ABCF2-uniprot.txt
      supporting_text: >-
        BINDING         430..437
- term:
    id: GO:0016887
    label: ATP hydrolysis activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      ABCF2 is an ABCF-family protein with two ABC nucleotide-binding domains,
      supporting annotation as an ATP-hydrolyzing ABC-family ATPase.
    action: ACCEPT
    reason: >-
      ATP hydrolysis activity is the most informative existing molecular
      function term for ABCF2. The biological process coupled to this ATPase
      activity remains uncertain; the ribosome-associated quality-control
      projection was not accepted without direct ABCF2 evidence.
    supported_by:
    - reference_id: file:human/ABCF2/ABCF2-uniprot.txt
      supporting_text: >-
        Belongs to the ABC transporter superfamily. ABCF family.
    - reference_id: PMID:28112439
      supporting_text: >-
        ABCF2 possesses nucleotide-binding domains, but has no transmembrane
        domains, which makes it different from other members of the ATP binding
        cassette family since it cannot function as a membrane transporter
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  qualifier: located_in
  review:
    summary: >-
      Cytosol localization is consistent with ABCF2 being a soluble ABCF-family
      protein lacking transmembrane domains.
    action: ACCEPT
    reason: >-
      The HPA-derived cytosol annotation matches the published description of
      ABCF2 as cytosolic and the UniProt caution that it lacks transmembrane
      domains.
    supported_by:
    - reference_id: PMID:28112439
      supporting_text: >-
        Among these genes, ABCF2, a cytosolic member of the ABC superfamily of
        transporters
    - reference_id: file:human/ABCF2/ABCF2-uniprot.txt
      supporting_text: >-
        Lacks transmembrane domains and is probably not involved in transport.
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9796042
  qualifier: located_in
  review:
    summary: >-
      Reactome models NFE2L2-dependent ABCF2 expression, but the primary
      evidence supports ABCF2 as a cytosolic, non-transmembrane ABCF protein
      rather than a plasma membrane transporter.
    action: REMOVE
    reason: >-
      The Reactome event is useful as NFE2L2 target-gene context, but plasma
      membrane localization is not supported by the cited primary literature and
      conflicts with the soluble ABCF-domain architecture.
    additional_reference_ids:
    - PMID:28112439
    supported_by:
    - reference_id: Reactome:R-HSA-9796042
      supporting_text: >-
        ABCF2 is an NFE2L2 target gene that contains a functional ARE sequence in
        the promoter which is confirmed through ChIP assay in Human Ovarian
        cancer cell lines.
    - reference_id: PMID:28112439
      supporting_text: >-
        Unlike other subgroups, ABCF members have NBDs but not TMDs, and thus do
        not function as transporters of molecules across the membrane.
    - reference_id: file:human/ABCF2/ABCF2-uniprot.txt
      supporting_text: >-
        Lacks transmembrane domains and is probably not involved in transport.
- term:
    id: GO:0016020
    label: membrane
  evidence_type: HDA
  original_reference_id: PMID:19946888
  qualifier: located_in
  review:
    summary: >-
      ABCF2 was identified in a high-throughput NK-cell membrane-proteome study,
      but the same study notes that many identified proteins were transient or
      nonintegral membrane-associated species.
    action: REMOVE
    reason: >-
      ABCF2 lacks transmembrane domains and is described in primary literature
      as cytosolic. The broad HDA membrane row is likely a fractionation or
      transient-association result rather than a defining localization.
    supported_by:
    - reference_id: PMID:19946888
      supporting_text: >-
        The remaining species were largely involved in cellular processes and
        molecular functions that could be predicted to be transiently associated
        with membranes.
    - reference_id: PMID:28112439
      supporting_text: >-
        Among these genes, ABCF2, a cytosolic member of the ABC superfamily of
        transporters
    - reference_id: file:human/ABCF2/ABCF2-uniprot.txt
      supporting_text: >-
        Lacks transmembrane domains and is probably not involved in transport.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: PMID:10944468
  title: cDNA cloning by amplification of circularized first strand cDNAs reveals
    non-IRE-regulated iron-responsive mRNAs.
  findings:
  - statement: >-
      ABCF2 was identified in a cloning study of mRNAs responsive to cellular
      iron levels, but this does not establish a GO process or transporter
      function.
    supporting_text: >-
      We tested this new method on eight mRNAs that we have previously shown to
      respond to cellular iron levels.
- id: PMID:16203778
  title: Identification of overexpression and amplification of ABCF2 in clear cell
    ovarian adenocarcinomas by cDNA microarray analyses.
  findings:
  - statement: >-
      ABCF2 copy number and expression are elevated in ovarian clear cell
      adenocarcinoma relative to serous cases, and cytoplasmic staining was
      higher in chemotherapy nonresponders.
    supporting_text: >-
      The results showed significantly higher ABCF2 DNA and mRNA copy number
      and protein levels in clear cell cases compared with those in serous cases.
- id: PMID:19946888
  title: Defining the membrane proteome of NK cells.
  findings:
  - statement: >-
      The high-throughput NK-cell membrane-proteome study identified many
      nonintegral or transiently membrane-associated proteins, making the broad
      ABCF2 membrane row weak.
    supporting_text: >-
      The remaining species were largely involved in cellular processes and
      molecular functions that could be predicted to be transiently associated
      with membranes.
- id: PMID:28112439
  title: ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian
    cancer cells.
  findings:
  - statement: >-
      ABCF2 is a cytosolic ABCF protein with nucleotide-binding domains but no
      transmembrane domains, distinguishing it from membrane transporters.
    supporting_text: >-
      ABCF2 possesses nucleotide-binding domains, but has no transmembrane
      domains, which makes it different from other members of the ATP binding
      cassette family since it cannot function as a membrane transporter
  - statement: >-
      NFE2L2/NRF2 regulates ABCF2 expression through a functional promoter ARE
      in ovarian cancer cells.
    supporting_text: >-
      To further confirm that NRF2 binds to the putative ARE of the ABCF2
      promoter, a CHIP assay was performed in A2780cp cells.
  - statement: >-
      Manipulating ABCF2 abundance changes cisplatin response in ovarian cancer
      cell-line assays, but the mechanism remains unresolved.
    supporting_text: >-
      ABCF2 overexpression rendered A2780 cells more resistant to cisplatin and
      ABCF2 knockdown rendered resistant A2780 cells more sensitive to cisplatin
- id: PMID:17064289
  title: Enteropathogenic Escherichia coli effector EspF interacts with host protein
    Abcf2.
  full_text_unavailable: true
  findings:
  - statement: >-
      ABCF2 (Abcf2) was identified by affinity purification as a binding partner
      of the enteropathogenic E. coli (EPEC) type III effector EspF, with the
      interaction confirmed by yeast two-hybrid, colocalization, and
      co-immunoprecipitation from infected cells. This is direct experimental
      evidence for an ABCF2 protein-protein interaction, surfaced by the Falcon
      deep research report.
  - statement: >-
      EPEC infection decreased ABCF2 levels in an EspF dose-dependent manner, and
      RNAi knockdown of ABCF2 increased EspF-induced caspase-9 and caspase-3
      cleavage and increased staurosporine-induced caspase-3 cleavage, indicating
      a putative anti-apoptotic (cytoprotective) function for ABCF2 that EspF
      antagonizes via the intrinsic/mitochondrial death pathway.
  - statement: >-
      ABCF2 was described as primarily cytoplasmic with partial mitochondrial
      localization in this study; this is consistent with influence on
      mitochondrial apoptosis but does not by itself justify a stable
      mitochondrial GO localization annotation without further evidence.
- id: Reactome:R-HSA-9796042
  title: NFE2L2 dependent ABCF2 expression
  findings:
  - statement: >-
      Reactome models ABCF2 as an NFE2L2 target gene with evidence from Bao et
      al. 2017; this supports transcriptional-regulation context, not plasma
      membrane localization.
    supporting_text: >-
      ABCF2 is an NFE2L2 target gene that contains a functional ARE sequence in
      the promoter which is confirmed through ChIP assay in Human Ovarian cancer
      cell lines.
- id: file:human/ABCF2/ABCF2-uniprot.txt
  title: UniProt record for ABCF2
  findings:
  - statement: >-
      UniProt annotates ABCF2 as an ABCF-family protein with two ABC transporter
      domains, two ATP-binding sites, and no transmembrane-domain transporter
      role.
    supporting_text: >-
      Lacks transmembrane domains and is probably not involved in transport.
- id: file:human/ABCF2/ABCF2-notes.md
  title: Manual notes for ABCF2 Proteostasis PN review
  findings: []
core_functions:
- molecular_function:
    id: GO:0016887
    label: ATP hydrolysis activity
  description: >-
    ABCF2 is a soluble ABCF-family ATPase with two ABC nucleotide-binding
    domains. Current evidence supports ATP binding and inferred ATP hydrolysis
    as the core molecular features, with cytosolic localization. ABCF-family
    members are reported to have translation/elongation roles, and UniProt
    places ABCF2 in the EF3 subfamily, but a direct biological process for the
    ABCF2 ATPase cycle is not established. The ribosome-associated
    quality-control projection is retained as a question rather than a new GO
    annotation.
  locations:
  - id: GO:0005829
    label: cytosol
  supported_by:
  - reference_id: file:human/ABCF2/ABCF2-uniprot.txt
    supporting_text: >-
      DOMAIN          86..325
  - reference_id: file:human/ABCF2/ABCF2-uniprot.txt
    supporting_text: >-
      DOMAIN          396..613
  - reference_id: PMID:28112439
    supporting_text: >-
      Unlike other subgroups, ABCF members have NBDs but not TMDs, and thus do
      not function as transporters of molecules across the membrane.
  - reference_id: PMID:28112439
    supporting_text: >-
      Instead, they are reported to be involved in protein translation and
      elongation
  - reference_id: file:human/ABCF2/ABCF2-uniprot.txt
    supporting_text: >-
      EF3 subfamily.
proposed_new_terms: []
suggested_questions:
- question: >-
    Does ABCF2 directly bind ribosomes or participate in ribosome-associated
    protein quality control, or is its PN placement under "other RQC processes"
    based on family/context inference?
- question: >-
    What substrates or client complexes are coupled to ABCF2 ATP hydrolysis in
    cytosol?
- question: >-
    By what molecular mechanism does ABCF2 abundance alter cisplatin sensitivity
    in ovarian cancer cells if it is not a membrane transporter?
- question: >-
    Does ABCF2 have a bona fide anti-apoptotic function at mitochondria, as
    suggested by the EspF-interaction study (PMID:17064289), and is the
    EspF-driven decrease in ABCF2 mediated by ubiquitin-dependent degradation?
suggested_experiments:
- description: >-
    Test endogenous ABCF2 association with translating ribosomes, collided
    ribosomes, and RQC factors by polysome profiling or ribosome co-sedimentation
    before and after ribosome-stalling treatments, followed by ABCF2 immunoblot
    or targeted mass spectrometry.
  hypothesis: >-
    ABCF2 will only justify a protein-quality-control GO annotation if it
    reproducibly associates with stalled-ribosome/RQC complexes.
- description: >-
    Purify ABCF2 and test ATPase activity with and without ribosomes, eIF
    factors, and candidate stress-response interactors, including ATPase-dead
    Walker motif mutants.
  hypothesis: >-
    ABCF2 is an active soluble ABC ATPase whose hydrolysis rate is stimulated by
    a specific cytosolic client complex.
